Stephen L Graziano, MD, 315 464-4353

Stephen L Graziano, MD
Appointed 12/10/07
Women's Health Network
2272 Regional Oncology Center
750 East Adams Street
Syracuse, NY 13210
315 464-4353

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology

Research Programs and Affiliations

  • Medicine


Education & Fellowships

  • Fellowship: University Hospital, SUNY Health Science Center at Syracuse, 1985
  • Residency: University Hospital, SUNY Health Science Center at Syracuse, 1982
  • Internship: University Hospital, SUNY Health Science Center at Syracuse, 1980
  • MD: University of Minnesota Medical School, 1979

Clinical Interests

  • Prognostic Factors in Patients with Non-Small Cell Lung Cancer; lung cancer clinical trials; participation in Cancer and Leukemia Group B studies.

Research Interests

  • Participation in Cancer and Leukemia Group B with  J. Bogart, L. Kohman, S. Lemke, J. Wright, B. Poiesz, K. Zamkoff, S. Grethlein and T. Coyle.

Clinical Trials

  • AACRU RC1126: A Randomized Phase II Trial of Erlotinib Alone or in Combination with Bevacizumab in Patients with Non-Small Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
    Read more
  • AFT-09: Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition with Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients with Chemotherapy Naive stage IV Non-small Cell Lung Cancer
    Read more
  • Alliance A081105 - Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
    Read more
  • CALGB 30901: Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients with Malignant Pleural Mesothelioma without Progression After First-line Chemotherapy
    Read more
  • ECOG E4512 - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
    Read more
  • Pfizer Protocol B7461001 - Phase 1/2 Study of PF-06463922 (an Alk/ros1 Tyrosine Kinase Inhibitor) in Patients With Advanced Non-Small Cell Lung Cancer Harboring Specific Molecular Alterations
    Read more
  • S1400 Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
    Read more
  • S1404: A Phase III Randomized Trial Comparing High Dose Interferon to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
    Read more

Specialties & Certification

  • Internal Medicine
  • Oncology
  • Hematology

Diseases & Conditions Treated

  • All Cancers and Hematological Conditions
  • Lung Cancer
  • Mesothelioma


  • Adults


  • Apheresis
  • Blood Transfusion
  • Bone Marrow Aspiration
  • Bone Marrow Biopsy
  • Bone Marrow Transplantation (BMT)
  • Chemotherapy
  • Clinical Trials
  • Conscious Sedation
  • Infusional Therapies
  • Lumbar Puncture
  • Paracentesis
  • Stem Cell Collection Procedures
  • Stem Cell Transplantation
  • Thoracentesis

Current Hospital Privileges

  • Upstate University Hospital


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)


Clinical Profile Shortcut:
Faculty Profile Shortcut: